Research Grade Rovelizumab
SKU: BTL-AS-A-16063 |
Host: Humanized |
Brand: Antibody System
Product Description
| Cat Number | DHC13102 |
|---|---|
| Category | Biosimilar Antibody |
| Pack Size | 100 μg |
| Applications | Research Grade Biosimilar |
| Target | Complement receptor C3 subunit beta, Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta, Integrin beta-2, MFI7, CD18, ITGB2, CD11A, Leukocyte function-associated molecule 1 alpha chain, Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A, CD11 antigen-like family member A, CD11a, ITGAL, Integrin alpha-L, CR-3 alpha chain, Cell surface glycoprotein MAC-1 subunit alpha, Leukocyte adhesion receptor MO1, ITGAM, CD11b, CD11 antigen-like family member B, Integrin alpha-M, CR3A, CD11B, Neutrophil adherence receptor |
| Clonality | Monoclonal |
| Synonyms | Bispecific, Hu23F2G, 23F2G, CAS: 339086-79-2 |
| Host | Humanized |
| Concentration | 1 mg/ml |
| Isotype | IgG4-nd |
| Form | Liquid |
| Buffer | 0.01M PBS, pH 7.4. |
| Purity | >95% by SDS-PAGE. |
| Specie Reactivity | Human |
| Note | The product is for research use only. |
Share Item: